Blog
California Governor Gavin Newsom Proposes State-Run Prescription Drug Label
In a move that could rock the pharmaceutical industry, California Governor Gavin Newsom announced his intent to create the first state-run prescription drug label in the U.S. This entity would
Synnex Corp (SNX) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
Synnex Corp (NYSE: SNX)Q4 2019 Earnings CallJan 9, 2020, 5:00 p.m. ET
Operator
Source Fool.com
Simulations Plus Inc (SLP) Q1 2020 Earnings Call Transcript
Image source: The Motley Fool.
Simulations Plus Inc (NASDAQ: SLP)Q1 2020 Earnings CallJan 9, 2020, 4:15 p.m. ET
Cameron Donahue -- Partner and Regional Vice President
Source Fool.co
Intuitive Surgical Reports Preliminary Fourth Quarter 2019 Results
Intuitive Surgical (NASDAQ: ISRG) recorded $1.28 billion in revenue in the fourth quarter, up 22% year over year, according to preliminary results released Thursday after the closing bell. Shares of
Why Micron Technology Stock Climbed 69% in 2019
Shares of Micron Technology (NASDAQ: MU) gained 69.5% last year, according to data provided by S&P Global Market Intelligence. That compares to a return of 28.9% for the S&P 500 index.
It was a
Am I a Pattern Day Trader?
Do you actively trade stocks? If so, it's important to know what it means to be a "pattern day trader" because there are requirements associated with engaging in pattern day trading. Once you
Why These 3 Oil and Gas Stocks Rose by Double Digits In December
Shares of stocks across the oil and gas industry surged in December. These included shares of independent exploration and production company Noble Energy (NYSE: NBL), and oilfield services companies
Here's Why CRISPR Therapeutics Stock Jumped 113.2% in 2019
Shares of CRISPR Therapeutics (NASDAQ: CRSP) rose over 113% last year, according to data provided by S&P Global Market Intelligence. The pharma stock built momentum throughout much of the year, but
Why AppFolio Stock Skyrocketed 85.7% in 2019
Shares of AppFolio (NASDAQ: APPF) roared 85.7% higher in 2019, according to data from S&P Global Market Intelligence, as the real estate and property management-centric software-as-a-service company
Why Heico Shares Plunged 12.1% in December
Shares of Heico (NYSE: HEI) fell 12.1% in December, according to data provided by S&P Global Market Intelligence, after earnings and a new acquisition were announced. Shares of the aerospace and
Why DXC Technology Stock Fell 29.3% in 2019
Shares of DXC Technology (NYSE: DXC) fell 29.3% in 2019, according to data from S&P Global Market Intelligence. The IT services company, which was born in 2017 from the merger of Computer Sciences
Medtronic Buys Spinal Cord Therapy Company, Adding To Its Chronic Pain Management Platform
Top medical device maker and popular healthcare stock Medtronic (NYSE: MDT) is now one asset larger. The company announced late Wednesday night that it acquired Stimgenics, a privately held
Here's Why Clovis Oncology Stock Sank 41.9% in 2019
Shares of Clovis Oncology (NASDAQ: CLVS) fell nearly 42% last year, according to data provided by S&P Global Market Intelligence. It could have been much worse. The pharma stock was sitting at a
The Simply Good Foods Company (SMPL) Q1 2020 Earnings Call Transcript
Image source: The Motley Fool.
The Simply Good Foods Company (NASDAQ: SMPL)Q1 2020 Earnings CallJan 9, 2020, 8:30 a.m. ET
Operator
Source Fool.com
The Best Dividend Stocks for 2020
Everyone dreams of kicking their feet up, relaxing, and watching money come in.
That's why dividend stocks are so popular -- you buy shares of a company and then sit back and let the payments come
Soft Demand Crimps Acuity's First-Quarter Profits
In my preview of lighting and controls manufacturer Acuity Brand's (NYSE: AYI) first-quarter fiscal 2020 earnings, I suggested that investors should expect volatility around the release. The market
Bristol-Myers Squibb's Celgene Unit Backs Out of a $55 Million Settlement
Bristol-Myers Squibb's (NYSE: BMY) Celgene unit, which the big pharma company acquired last year, has backed out of a $55 million settlement agreement with patients and payers over claims that it
Why AMC Entertainment's Stock Crashed Hard in 2019
Movie theater chain AMC Entertainment Holdings (NYSE: AMC) had a hit-and-miss year in 2019, but the misses outclassed the hits. The stock fell 41% last year, according to data from S&P Global Market
Why Enphase Energy Shares Rose 19.5% in December and Are Still on Fire
Shares of solar microinverter company Enphase Energy (NASDAQ: ENPH) jumped 19.5% in December, according to data provided by S&P Global Market Intelligence, as investors became bullish on the
Here's Why Bloom Energy Dropped 25.1% in 2019
Shares of Bloom Energy (NYSE: BE) fell more than 25% last year, according to data provided by S&P Global Market Intelligence. It could have been much worse. The fuel cell stock was down nearly 80%
Why Shares of Axon Enterprise Gained 67% in 2019
Shares of Axon Enterprise (NASDAQ: AAXN) climbed 67.5% in 2019, according to data provided by S&P Global Market Intelligence, but investors had to stomach a good deal of volatility before it reached
Here's Why Stericycle's Shares Soared 73.9% in 2019
After the company spent the previous couple years in the doldrums, a turnaround strategy helped spark a 73.9% rally in Stericycle's (NASDAQ: SRCL) shares in 2019, according to S&P Global Market
Here's Why Shares of J.C. Penney Are Down Today
Shares of J.C. Penney (NYSE: JCP) traded down more than 11% on Thursday after the struggling retailer reported weak holiday sales. The results were actually within range of what the company had
Why Axonics Modulation Technologies Is Skyrocketing 24.5% Today
After management offered an early look at the company's fourth-quarter financial results, Axonics Modulation Technologies (NASDAQ: AXNX) shares are rocketing 24.5% higher at 1:00 p.m. EST on
Why the FDA's Decision on Aimmune's Peanut Allergy Drug Is Crucial for the Company -- and Patients
Aimmune Therapeutics' (NASDAQ: AIMT) share price has gained 11% over the past month as the company waits for the Food and Drug Administration to issue an approval decision on its very first drug